Clinical Trial Update: Macrophage Phagocytosis in COPD

View source ↗

Summary

A completed clinical trial from Imperial College London investigating macrophage phagocytosis in COPD with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Imperial College London | Conditions: Chronic Obstructive Pulmonary Disease, Emphysema | Status: COMPLETED | Results posted: 2019-11-22